This protocol is judged by an institutional assessment board, an impartial group that evaluations any clinical trials involving humans. If a study entails a Program I drug, when the board approves the protocol as ethical, the researchers must submit an application for an investigational new drug (IND) range through the FDA.The good thing is, other